Detect is advancing a differentiated point-of-care molecular diagnostics platform designed to bring laboratory-quality testing closer to where patients receive care.
Detect is a privately held company focused on advancing molecular diagnostics for women’s health. This section provides information for current and prospective investors.
Questions about Detect or your investment? Please contact our Investor Relations team for assistance with shareholder inquiries, access to our Carta Equity Management system, corporate information, or investor resources.
Michael Bourgeault
Vice President, Finance
mbourgeault@detect.com